Moreover, the binding of the SARS-CoV-2 to the angiotensin-converting enzyme receptors causes a subsequent decrease in the angiotensin-converting enzyme-II (ACE2), abnormally high blood pressure, and increased risk of hemorrhagic stroke. The gene discussed is ACE2; the disease is blood pressure trait.